MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer

Carcinogenesis

Volumn 34, Issue 3, 2013, Pages 713-722

  Liang, Yong Jun ^a,b   Wang, Qiu Yu ^a   Zhou, Ci Xiang ^a   Yin, Qian Qian ^b   He, Ming ^a   Yu, Xiao Ting ^a   Cao, Dan Xia ^a   Chen, Guo Qiang ^a,b   He, Jian Rong ^a   Zhao, Qian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 124; TRANSCRIPTION FACTOR SLUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; PRIORITY JOURNAL;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES, RENILLA; LUNG NEOPLASMS; MICE; MICE, SCID; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TUMOR BURDEN;

EID: 84874787674     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs383     Document Type: Article

References (37)

1. Gonzalez-Angulo, A.M. et al. (2007) Overview of resistance to systemic therapy in patients with breast cancer. Adv. Exp. Med. Biol., 608, 1-22.
2. Slamon, D.J. et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182.
3. Varley, J.M. et al. (1987) Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene, 1, 423-430.
4. Ford, D. et al. (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet., 57, 1457-1462.
5. Valastyan, S. et al. (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell, 147, 275-292.
6. Taube, J.H. et al. (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. U.S.A., 107, 15449-15454.
7. Singh, A. et al. (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene, 29, 4741-4751.
8. Polyak, K. et al. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer, 9, 265-273.
9. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
10. Valastyan, S. et al. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 137, 1032-1046.
11. Marilena, V. et al. (2012) microRNA involvement in human cancer. Carcinogenesis, 33, 1126-1133.
12. Chen, C.Z. (2005) MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med., 353, 1768-1771.
13. Ma, L. et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol., 12, 247-256.
14. Huang, Q. et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol., 10, 202-210.
15. Burk, U. et al. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep., 9, 582-589.
16. Park, S.M. et al. (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev., 22, 894-907.
17. Gregory, P.A. et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol., 10, 593-601.
18. Lee, M.R. et al. (2010) miR-124a is important for migratory cell fate transition during gastrulation of human embryonic stem cells. Stem Cells, 28, 1550-1559.
19. Cheng, L.C. et al. (2009) miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci., 12, 399-408.
20. Xia, H. et al. (2012) Loss of brain-enriched miR-124 microRNA enhances stemlike traits and invasiveness of glioma cells. J. Biol. Chem., 287, 9962-9971.
21. Hunt, S. et al. (2011) MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett., 585, 187-192.
22. Furuta, M. et al. (2010) miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis, 31, 766-776.
23. Zheng, F. et al. (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut, 61, 278-289.
24. Lv, X.B. et al. (2011) miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Chin. J. Cancer, 30, 821-830.
25. Calin, G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
26. Iorio, M.V. et al. (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med., 4, 143-159.
27. Lu, J. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
28. Kalluri, R. et al. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest., 119, 1420-1428.
29. Tanno, B. et al. (2010) Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. J. Biol. Chem., 285, 29434-29445.
30. Mittal, M.K. et al. (2011) SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination. J. Biol. Chem., 286, 469-479.
31. Bhat-Nakshatri, P. et al. (2010) SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer, 10, 411-426.
32. Cobaleda, C. et al. (2007) Function of the zinc-finger transcription factor SNAI2 in cancer and development. Annu. Rev. Genet., 41, 41-61.
33. Wang, S.P. et al. (2009) p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat. Cell Biol., 11, 694-704.
34. Lujambio, A. et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res., 67, 1424-1429.
35. Wong, K.Y. et al. (2011) Epigenetic inactivation of the miR-124-1 in haematological malignancies. PLoS ONE, 6, e19027.
36. Silber, J. et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med., 6, 14-30.
37. Wilting, S.M. et al. (2010) Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol. Cancer, 9, 167-180.